Showing results (361-370 of 434) with videos related to
Sort By:
Pageof 44
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2012
Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumorsJeffrey R Infante, D Ross Camidge, Linda R Mileshkin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2013
Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancerThida Win, Kenneth A Miles, Sam M Janes, et al.The Lancet. Oncology|May 13, 2018
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 studyMichael S Hofman, John Violet, Rodney J Hicks, et al.Journal for Immunotherapy of Cancer|October 16, 2020
Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinomaAlison M Weppler, Andrew Pattison, Prachi Bhave, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2014
Multifunctional imaging signature for V-KI-RAS2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations in colorectal cancerKenneth A Miles, Balaji Ganeshan, Manuel Rodriguez-Justo, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2024
Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumoursSeval Beykan Schürrle, Uta Eberlein, Catherine Ansquer, et al.Frontiers in Endocrinology|December 14, 2023
Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitisAnna Galligan, Amir Iravani, Arian Lasocki, et al.The Lancet. Oncology|November 3, 2009
Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009Joseph T Wee, Benjamin O Anderson, June Corry, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 23, 2022
Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancerSofia C Vaz, Judit A Adam, Roberto C Delgado Bolton, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 13, 2022
Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0Sofia C Vaz, Judit A Adam, Roberto C Delgado Bolton, et al.Pageof 44